Public Health Agency of Canada
Symbol of the Government of Canada

E-mail this page





Evaluation of Food Fortification with Folic Acid for the Primary Prevention of Neural Tube Defects

References

Balk HW, Russell RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr 1999; 19:357- 77.

Canada Gazette Part II. Regulatory impact analysis statement, SOR/98-550, vol 132 (24):3029-33. 1998.

Canada Gazette Part II. Food and drug regulations -amendment SOR/96-527, vol.130 (26):3318-20, 1996.

Canadian Task Force on the Periodic Health Examination, Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. CMAJ 1994;151:159-66.

Centers for Disease Control and Prevention (CDC). Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep. 1992; 41:1-7.

Choumenkovitch SF, Selhub J, Wilson PW, Rader JI, Rosenberg IH, Jacques PF. Folic acid intake from fortification in United States exceeds predictions. J Nutr 2002: 132:2972-78.

Crane JMG, Sun C, Hutchens D, Crowley M. The epidemiology of neural tube defects inNewfoundland and Labrador. J Soc Obstet Gynaecol Can 2001; 23:510-4.

Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327:1832-5.

Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Federal Register 1996; 61:8781-97.

Gucciardi E, Pietrusiak MA, Reynolds DL, Rouleau J. Incidence of neural tube defects in Ontario, 1986-1999. CMAJ 2002; 167:237-40.

Health Canada. Canadian Perinatal Health Report 2000. Ottawa: Minister of Public Works and Government Services Canada, 2000; pp 100-2.

Health Canada. Folic acid: the vitamin that helps protect against neural tube (birth) defects. Issues April 9,1993.

Institute of Medicine. Folate. In: Dietary reference intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline, pp. 196-305. National Academy Press, Washington, DC. 1998.

Laurence KM, James N, Miller MM, Tennant GB, Campbell H. Double- blinded randomized controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. Br Med J (Clin Res Ed) 1981; 282:1509-11.

MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338:131-7.

Persad VL, Van den Hof MC, Dubé JM, Zimmer P. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 2002; 167:241-5.

Smithells RW, Nevin NC, Seller MJ, Sheppard S, Harris R, Read AP, et al. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1983;1:1027-31.

Turner LA, McCourt C. Folic acid fortification: What does it mean for patients and physician? CMAJ 1998; 158:773-4.

Willett WC, Reynolds RD, Cottrell-Hoehner S, Sampson L, Browne ML. Validation of a semi-quantitative food frequency questionnaire: Comparison with a 1-year diet record. J Am Diet Assoc 1987; 87:43-7.

Willett WC, Sampson L, Browne ML, Stamphar MJ, Rosner B. Hennekens CH, et al. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 1988; 127:188-99.